Driving Better Titers and Shorter Timelines with a Robust and Scalable CHO DG44 Platform

On-Demand Webinar - Driving Better titers and Shorter Timelines with a Robust and Scalable CHO DG44 Platform

Watch this on-demand webinar held on October 06, 2022, to learn more about the challenges for developing new generation vectors and effective process improvements to increase the utility of CHO DG44 as a cell line development platform.

In this webinar, Dr. Sufia Karim, Director, Cell Line Development, Aragen Life Sciences will highlight on:

Challenges faced while using the dihydrofolate reductase (DHFR)-deficient CHO DG44 platform
New generation vectors and process design improvements to improve CHO DG44 as a cell line development platform

Speaker

Dr. Sufia Karim
Director Cell Line Development
Aragen Life Sciences

Please fill the form to see the webinar

FIRST NAME

✽

LAST NAME

✽

EMAIL

✽

COMPANY

✽

COUNTRY

✽

MESSAGE

I AGREE

By submitting this form you agree to our Privacy Policy concerning the way Aragen may use your personal information.

.